Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01878032 · ClinicalTrials.gov registry record
Color Vision as a Measure for Inherited Retinal Diseases
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 166
- Enrollment target
NCT01878032: Completed study, sponsored by National Eye Institute (NEI).
NCT01878032 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01878032 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
Background: \- The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRDs). IRDs are a major cause of vision loss worldwide, but very little is known about how the diseases affect color vision over time. This study will tell us if color vision may be used to track changes in inherited retinal diseases over time. Objectives: \- To improve understanding of color vision as a way to measure changes in inherited retinal diseases. Eligibility: * People 5 years of age or older who have an IRD. * Healthy volunteers at least 5 years of age. Design: * Participants will make at least one visit to the National Eye Institute clinic. If they sign up for more tests, they may have up to three visits to the NEI clinic. * Participants will be asked questions about their medical and eye history. * Participants will be given an eye exam, including eye drops to dilate their pupils. They will take the Cambridge Color Test, which includes looking at a monitor and pressing a button, and arranging colored circles. Several other tests may be offered, but participants can decline to take them. * Treatment will not be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2013-06-03 |
| Est. Completion | 2017-04-14 |
What the finished NCT01878032 record still lists
NCT01878032 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01878032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01878032 about?
NCT01878032 is a clinical study titled "Color Vision as a Measure for Inherited Retinal Diseases". Background: \- The purpose of this study is to find out whether color vision measured with the Cambridge Color Test is a good way to examine the severity of inherited retinal diseases (IRDs). IRDs are a major cause of vision loss worldwide, but very little is known about how the diseases affect col...
What is the current status of trial NCT01878032?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2013-06-03. Estimated completion is 2017-04-14.
Who is sponsoring clinical trial NCT01878032?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI